|
Nicox SA - Company Profile Snapshot
| Company Profile: |
Nicox SA |
| Ticker: |
7413 |
| Exchanges: |
PAR |
| 2008 Sales: |
3,362,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
FRANCE |
| Employees: |
133 |
Business Description
Nicox SA. The Group's principal activity is to develop nitric-oxide donating drugs targeting the therapeutic area. The Group offers biopharmaceutical therapeutics to treat ailments such as osteoarthritis, diabetes, inflammation and cardio metabolic diseases. The Group markets its products under the brand names Naproxcinod, NCX 4016 and NCX 6560. The Group also works in association with major pharmaceutical companies such as Pfizer, Merck and Group Ferrer. The Group operates in France.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
